IR@PKUHSC  > 北京大学临床肿瘤学院  > 药剂科
学科主题临床医学
Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer
Zhang, Hui-Qing1; Lian, Chang-Hong1; Ping, Yao-Dong3; Song, Wen-Bin1; Lu, Qing-Pu; Xie, Shu-Zhe; Lin, Tao; Cheng, Lin-Zhong2
关键词Metastatic colorectal cancer pemetrexed chemotherapy response rate
刊名ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
2014
DOI10.7314/APJCP.2014.15.19.8391
15期:19页:8391-8394
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]PLUS IRINOTECAN ; PHASE-II ; MULTITARGETED ANTIFOLATE ; LY231514 ; CHEMOTHERAPY ; CARCINOMA ; DISODIUM ; ENZYMES
英文摘要

Purpose: This systematic analysis was conducted to evaluate the efficacy and safety of pemetrexed based salvage chemotherapy for treatment of patients with metastatic colorectal cancer. Methods: Clinical studies evaluating the efficacy and safety of pemetrexed based regimens on response and safety for patients with colorectal cancer were identified using a predefined search strategy. Pooled response rates (RRs) were calculated. Results: For pemetrexed based regimens, 4 clinical studies including 201 patients with advanced colorectal cancer were considered eligible for inclusion. The analysis suggested that, in all patients, pooled RR was 20.4% (41/201). Major adverse effects were neutropenia, anorexia, fatigue, and anemia. No treatment related death occurred with pemetrexed based treatment. Conclusion: This systematic analysis suggests that pemetrexed based regimens are associated with mild activity with good tolerability in treating patients with metastatic colorectal cancer.

语种英语
WOS记录号WOS:000343833800058
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66928
专题北京大学临床肿瘤学院_药剂科
作者单位1.Heping Hosp, Changzhi Med Coll, Dept Gen Surg, Changzhi, Shanxi, Peoples R China
2.Heping Hosp, Changzhi Med Coll, Dept Pharm, Changzhi, Shanxi, Peoples R China
3.Peking Univ, Dept Pharm, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Hui-Qing,Lian, Chang-Hong,Ping, Yao-Dong,et al. Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer[J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION,2014,15(19):8391-8394.
APA Zhang, Hui-Qing.,Lian, Chang-Hong.,Ping, Yao-Dong.,Song, Wen-Bin.,Lu, Qing-Pu.,...&Cheng, Lin-Zhong.(2014).Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION,15(19),8391-8394.
MLA Zhang, Hui-Qing,et al."Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer".ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 15.19(2014):8391-8394.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Hui-Qing]的文章
[Lian, Chang-Hong]的文章
[Ping, Yao-Dong]的文章
百度学术
百度学术中相似的文章
[Zhang, Hui-Qing]的文章
[Lian, Chang-Hong]的文章
[Ping, Yao-Dong]的文章
必应学术
必应学术中相似的文章
[Zhang, Hui-Qing]的文章
[Lian, Chang-Hong]的文章
[Ping, Yao-Dong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。